Power of Story
Send a Tweet        
- Advertisement -

Share on Google Plus 1 Share on Twitter 4 Share on Facebook 2 Share on LinkedIn Share on PInterest 1 Share on Fark! Share on Reddit Share on StumbleUpon 1 Tell A Friend 6 (15 Shares)  

Printer Friendly Page Save As Favorite View Favorites (# of views)   15 comments
General News

Is the Appointment of Robert Califf FDA Deputy Commissioner for Medical Products and Tobacco a JOKE?

By       Message Martha Rosenberg     Permalink
      (Page 1 of 3 pages)
Related Topic(s): ; ; ; ; ; ; ; ; , Add Tags Add to My Group(s)

Must Read 4   Well Said 4   News 3  
View Ratings | Rate It

opednews.com Headlined to H1 2/5/15

Author 1353
Become a Fan
  (79 fans)
- Advertisement -

You have probably heard "the FDA is too friendly to industry" but many would not believe how friendly. It took a reporter at the Philadelphia Inquirer to expose that a paid consultant to AstraZeneca was a voting member on the FDA committee voting on an AstraZeneca drug, Seroquel. Otherwise the vote would have gone through. Now you can barely find a trace that the AstraZeneca consultant, child psychiatrist Jorge Armenteros, ever graced an FDA committee much less headed one.

Many had high hopes for the FDA when Margaret Hamburg was confirmed as Commissioner in 2009 because of her public health orientation--but she swiftly moved to loosen conflict of interest rules governing those who can serve on FDA expert advisory panels, claiming it was too hard to find experts without Pharma financial links. What?

- Advertisement -

More recently Senators Joe Manchin (D-"W.Va.) and David Vitter (R-"La.) questioned whether the FDA's recent approval of the synthetic opioid Zohydro stemmed from pay-to-play"meetings with Big Pharma who allegedly shelled out thousands to meet with regulators. Big Pharma's hand in the opioid epidemic which causes 17,000 overdose deaths a year in the U.S. is well documented and egregious.

Last month a shocking FDA appointment suggests the FDA is no longer even making a pretense at policing industry/government conflicts of interest. Commissioner Hamburg appointed Robert Califf, M.D., chancellor of clinical and translational research at Duke University, as the next FDA Deputy Commissioner for Medical Products and Tobacco despite a thicket of conflicts of interest.

- Advertisement -

A disclosure statement on the website of Duke Clinical Research Institute says "Robert M. Califf, MD, reports receiving research grant support from NovartisPharmaceuticals, Johnson & Johnson/Scios, Lilly, Merck, and Schering

Plough, and consulting fees from Annenberg, Aterovax, Bayer/Ortho McNeil,BMS, Boehringer Ingelheim, GSK, WebMd/theheart.org, Johnson and ohnson/Scios, Kowa Research Institute, McKinsey & Company, Medtronic, Merck, Novartis Pharmaceuticals, Sanofi Aventis, and Schering Plough, and has an equity position with NITROX, LLC. "

And there's more! In disclosure information for a 2013 article in Circulation, Dr. Califf's also lists financial links to Gambro, Regeneron, Gilead, AstraZeneca, Roche, others companies and equity positions in four medical companies. The medical website Medscape discloses that Dr. Califf "served as a director, officer, partner, employee, advisor, consultant or trustee for Genentech" as well as for Medscape LLC/theheart.org. Portola Pharmaceuticals says Dr. Califf served on the Board of Directors until he was appointed FDA Deputy Commissioner for Medical Products and Tobacco.

- Advertisement -


FDA--an arm of Big Pharma?
(Image by Martha Rosenberg)
  Permission   Details   DMCA

This is not the first time Dr. Califf's extreme Pharma links have not blocked him from consideration for a top government post. He was up for Dr. Hamburg's job itself, reported Reuters along with three others. At the time, some medical voices asked how someone who helps drug companies market their products could possibly be considered as the nation's chief watchdog over unsafe medications. It sounded like a satire in the Onion. Six years later their concerns have come to pass: the fox is guarding the hen house.

Next Page  1  |  2  |  3

 

- Advertisement -

Must Read 4   Well Said 4   News 3  
View Ratings | Rate It

Martha Rosenberg is an award-winning investigative public health reporter who covers the food, drug and gun industries. Her first book, Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health, is distributed by Random (more...)
 

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon



Go To Commenting
/* The Petition Site */
The views expressed in this article are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Writers Guidelines

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
- Advertisement -

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Grassley Investigates Lilly/WebMD link Reported by Washington Post

The Drug Store in Your Tap Water

It's the Cymbalta Stupid

Are You Sure You're Not Psychotic Asks Shameless Drug Company?

Another Poorly Regulated "Derivative"--the Antidepressant Pristiq

MRSA and More. Antibiotics Linked to Obesity and Allergies, Too